WallStreetZenWallStreetZen

NASDAQ: BFRI
Biofrontera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for BFRI

Based on 2 analysts offering 12 month price targets for Biofrontera Inc.
Min Forecast
$7.00+1,361.38%
Avg Forecast
$7.00+1,361.38%
Max Forecast
$7.00+1,361.38%

Should I buy or sell BFRI stock?

Based on 2 analysts offering ratings for Biofrontera Inc.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BFRI stock forecasts and price targets.

BFRI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Benchmark
Bottom 8%
8
Strong BuyReiterates$7.00+1,361.38%2023-05-15
Benchmark
Top 20%
81
Strong BuyReiterates$7.00+1,361.38%2023-03-09

1 of 1

Forecast return on equity

Is BFRI forecast to generate an efficient return?
Company
N/A
Industry
0.05%
Market
71.96%

Forecast return on assets

Is BFRI forecast to generate an efficient return on assets?
Company
N/A
Industry
0.03%

BFRI revenue growth forecast

How is BFRI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
73.04%
Industry
8.48%
Market
8.43%
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BFRI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BFRI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
BFRI$0.48$7.00+1,361.38%Strong Buy
CLVR$0.27N/AN/A
PAVS$2.95N/AN/A
ACRX$1.03N/AN/A
SBFM$0.67N/AN/A
View Top Pharmaceutical Stocks

Biofrontera Stock Forecast FAQ

Is Biofrontera Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BFRI) stock is to Strong Buy BFRI stock.

Out of 2 analysts, 2 (100%) are recommending BFRI as a Strong Buy, 0 (0%) are recommending BFRI as a Buy, 0 (0%) are recommending BFRI as a Hold, 0 (0%) are recommending BFRI as a Sell, and 0 (0%) are recommending BFRI as a Strong Sell.

If you're new to stock investing, here's how to buy Biofrontera stock.

What is BFRI's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: BFRI) forecast ROE is N/A, which is considered weak.

What is BFRI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BFRI price target, the average BFRI price target is $7.00, with the highest BFRI stock price forecast at $7.00 and the lowest BFRI stock price forecast at $7.00.

On average, Wall Street analysts predict that Biofrontera's share price could reach $7.00 by May 15, 2024. The average Biofrontera stock price prediction forecasts a potential upside of 1,361.38% from the current BFRI share price of $0.48.

What is BFRI's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: BFRI) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.